Literature DB >> 29339962

Three New PAX2 Gene Mutations in Patients with Papillorenal Syndrome.

Alberto Galvez-Ruiz1, Anthony J Lehner2, Alicia Galindo-Ferreiro1, Patrik Schatz1,3.   

Abstract

Papillorenal syndrome (PAPRS; Mendelian Inheritance in Man [MIM] 120330) is an autosomal dominant disease characterised by the presence of congenital renal and optic nerve abnormalities associated with mutations of the PAX2 gene. In this article, the authors present four patients with PAPRS who are carriers of three new PAX2 mutations, as well as another patient with a possible non-pathogenic variant of the PAX2 gene. All patients were given a full neurophthalmological examination, and all patients underwent a genetic test for PAX2. Patients 1 and 2 presented with the classic signs of PAPRS: renal disease associated with a congenitally abnormal optic disc, whereas patients 3 and 4 only presented with a congenital optic nerve abnormality and no renal involvement. In patients 1 and 2, the optic nerves were affected by the presence of a central excavation within the optic disc, absence of the central retinal artery, as well as multiple cilioretinal arteries radiating from the periphery of the optic disc. Bilateral optic nerve pits were seen in patient 3, and lastly, in patient 4 there was the presence of superficial gliotic tissue on the left optic disc. All patients presented with a missense mutation in the PAX2 gene, where in patient 4 possibly being only a non-pathogenic variant of the gene. In conclusion, the authors present two patients with classic clinical signs of PAPRS, having two new PAX2 mutations, which until now have not been described in the current literature; another patient with a new PAX2 mutation showing only ocular manifestations of the disease, and lastly, a patient who is a carrier of a variant of the PAX2 gene has a congenitally abnormal optic disc, which is probably not related to PAPRS.

Entities:  

Keywords:  Multicystic dysplastic kidney; PAX2 gene; papillorenal syndrome; renal coloboma syndrome; renal hypoplasia

Year:  2017        PMID: 29339962      PMCID: PMC5762175          DOI: 10.1080/01658107.2017.1307995

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  11 in total

1.  [On the clinical picture of Handmann's anomaly of the optic nerve Morning glory syndrome? (author's transl)].

Authors:  G Rieger
Journal:  Klin Monbl Augenheilkd       Date:  1977-05       Impact factor: 0.700

2.  Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database.

Authors:  Matthew Bower; Rémi Salomon; Judith Allanson; Corinne Antignac; Francesco Benedicenti; Elisa Benetti; Gil Binenbaum; Uffe B Jensen; Pierre Cochat; Stephane DeCramer; Joanne Dixon; Regen Drouin; Marni J Falk; Holly Feret; Robert Gise; Alasdair Hunter; Kisha Johnson; Rajiv Kumar; Marie Pierre Lavocat; Laura Martin; Vincent Morinière; David Mowat; Luisa Murer; Hiep T Nguyen; Gabriela Peretz-Amit; Eric Pierce; Emily Place; Nancy Rodig; Ann Salerno; Sujatha Sastry; Tadashi Sato; John A Sayer; Gerard C P Schaafsma; Lawrence Shoemaker; David W Stockton; Wen-Hann Tan; Romano Tenconi; Philippe Vanhille; Abhay Vats; Xinjing Wang; Berta Warman; Richard G Weleber; Susan M White; Carolyn Wilson-Brackett; Dina J Zand; Michael Eccles; Lisa A Schimmenti; Laurence Heidet
Journal:  Hum Mutat       Date:  2012-01-31       Impact factor: 4.878

3.  Macular abnormalities and optic disk anomaly associated with a new PAX2 missense mutation.

Authors:  Tomomi Higashide; Takashi Wada; Mayumi Sakurai; Hitoshi Yokoyama; Kazuhisa Sugiyama
Journal:  Am J Ophthalmol       Date:  2005-01       Impact factor: 5.258

4.  Early diagnosis of the papillorenal syndrome by optic disc morphology.

Authors:  Arif O Khan; Sawsan R Nowilaty
Journal:  J Neuroophthalmol       Date:  2005-09       Impact factor: 3.042

Review 5.  Renal coloboma syndrome.

Authors:  Lisa A Schimmenti
Journal:  Eur J Hum Genet       Date:  2011-06-08       Impact factor: 4.246

6.  Redefining papillorenal syndrome: an underdiagnosed cause of ocular and renal morbidity.

Authors:  C F Parsa; E D Silva; O H Sundin; M F Goldberg; M R De Jong; J S Sunness; R Zeimer; D G Hunter
Journal:  Ophthalmology       Date:  2001-04       Impact factor: 12.079

7.  Pax2 expression and retinal morphogenesis in the normal and Krd mouse.

Authors:  D C Otteson; E Shelden; J M Jones; J Kameoka; P F Hitchcock
Journal:  Dev Biol       Date:  1998-01-15       Impact factor: 3.582

8.  Papillorenal syndrome-causing missense mutations in PAX2/Pax2 result in hypomorphic alleles in mouse and human.

Authors:  Ramakrishna P Alur; Camasamudram Vijayasarathy; Jacob D Brown; Mohit Mehtani; Ighovie F Onojafe; Yuri V Sergeev; Elangovan Boobalan; Marypat Jones; Ke Tang; Haiquan Liu; Chun-Hong Xia; Xiaohua Gong; Brian P Brooks
Journal:  PLoS Genet       Date:  2010-03-05       Impact factor: 5.917

9.  Missense mutation and hexanucleotide duplication in the PAX2 gene in two unrelated families with renal-coloboma syndrome (MIM 120330).

Authors:  K Devriendt; G Matthijs; B Van Damme; D Van Caesbroeck; M Eccles; Y Vanrenterghem; J P Fryns; A Leys
Journal:  Hum Genet       Date:  1998-08       Impact factor: 4.132

10.  The Opdc missense mutation of Pax2 has a milder than loss-of-function phenotype.

Authors:  Sally H Cross; Lisa McKie; Katrine West; Emma L Coghill; Jack Favor; Shoumo Bhattacharya; Steve D M Brown; Ian J Jackson
Journal:  Hum Mol Genet       Date:  2010-10-13       Impact factor: 6.150

View more
  2 in total

1.  New PAX2 Mutation Associated with Polycystic Kidney Disease: A Case Report.

Authors:  Jessica Maria Forero-Delgadillo; Vanessa Ochoa; Natalia Duque; Jaime Manuel Restrepo; Hernando Londoño; Jose Antonio Nastasi-Catanese; Harry Pachajoa
Journal:  Clin Med Insights Pediatr       Date:  2021-03-05

Review 2.  The Role of PAX2 in Neurodevelopment and Disease.

Authors:  Na Lv; Ying Wang; Min Zhao; Lina Dong; Hongen Wei
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-07       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.